Glaxo Wellcome earmarks more for research

Pharmaceutical giant Glaxo Wellcome spent Pounds 1.15 billion on research and development in 1997, according to its annual report. The firm, which notched up global sales worth Pounds 8 billion, says it expects to spend Pounds 1.2 billion on R&D next year. It says that for the pharmaceutical industry worldwide, sales in 1997 were up 9 per cent to Pounds 166 billion.The North American market saw the greatest increase from 9 per cent growth in 1996 to 15 per cent in 1997, generating Pounds 61 billion of sales.

The United States accounts for 35 per cent of the global market. Europe has experienced a decline in growth from 9 per cent to 6 per cent. Growth in Latin America has increased from 7 per cent to 11 per cent, while in Asia Pacific growth has slowed from 13 per cent to 9 per cent.

Already registered?

Sign in now if you are already registered or a current subscriber. Or subscribe for unrestricted access to our digital editions and iPad and iPhone app.

Register to continue  

You've enjoyed reading five THE articles this month. Register now to get five more, or subscribe for unrestricted access.

Most Commented

  • Woman taking homeopathic medicine

Alternative treatments in healthcare plan is latest in a series of homeopathy-related controversies

  • Man lying beneath rugby pile-up

Six academics share their experiences before delivering a verdict on the system

  • Zygmunt Bauman with hand over mouth

Eminent sociologist has recycled 90,000 words of material across a dozen books, claims paper

  • Foot about to step on banana peel

Kevin Haggerty and Aaron Doyle offer tips on making postgraduate study even tougher (which students could also use to avoid pitfalls if they prefer)

  • Sorana Vieru, National Union of Students

Sorana Vieru says exams and essays 'privilege' more advantaged students, calls for changes to 'Middle Ages' format